During Tuesday’s Current trade, Shares of Service Corporation International(NYSE:SCI), lost -0.78% to $28.00.
Service Corporation International (SCI), North America’s largest provider of funeral and cemetery services, has ramped up its steadfast commitment to the city of New Orleans since the December 2013 acquisition of Stewart Enterprises with a $7.2 million capital improvement plan designed to spotlight several historic cemeteries counting Mount Olivet Cemetery and Metairie Cemetery in addition to Lake Lawn Metairie Funeral Home.
SCI has accomplished the first half of its multi-million dollar capital improvement plan with the final phase of the project culminating in 2016. Enhancements comprise renovations to existing structures, a new mausoleum in addition to a new cremation garden, with most of the construction sourced by local contractors.
Service Corporation International, together with its auxiliaries, provides deathcare products and services in the United States and Canada. The company operates through Funeral and Cemetery segments. Its funeral service and cemetery operations comprise funeral service locations, cemeteries, funeral service/cemetery combination locations, crematoria, and related businesses.
Shares of Toronto-Dominion Bank(NYSE:TD), declined -2.52% to $38.68, during its current trading session.
Slowing activity in China and other emerging market economies will be a headwind to growth over the next year, but the U.S. economy is in good shape to weather the storm, according to a report released recently by TD Economics (www.td.com/economics), an associate of TD Bank, America’s Most Convenient Bank®.
Led by consumer spending, economic growth is predictable to average 2.5% on an annual average basis in 2015, before rising to 2.6% in 2016. With the unemployment rate falling to 4.8% and the Fed in the midst of a gradual tightening cycle, growth is predictable to slow modestly to 2.4% in 2017.
China’s growing pains spread to the rest of the world
The chief cause for concern for the economic outlook is the slowdown in China and its ramifications for the rest of the world. Unease reached a fever pitch in August, following steep declines in the Chinese equity market and a decision by the central bank to devalue the Chinese yuan. Contagion spread to equity markets around the world and led the U.S. dollar to rise against a range of global currencies.
The Toronto-Dominion Bank, together with its auxiliaries, provides financial and banking services in North America and internationally. The company operates through Canadian Retail, U.S. Retail, and Wholesale Banking segments. The Canadian Retail segment offers various financial products and services, in addition to telephone, Internet, and mobile banking services to about 15 million personal and small business customers through a network of 1,165 branches and 2,867 automated banking machines in Canada.
Hologic, Inc.(NASDAQ:HOLX), during its Tuesday’s current trading session decreased -1.44% to $41.16.
Hologic, Inc. (HOLX) declared that U.S. mammography providers gave Hologic and Hologic’s Genius™ 3D Mammography™ exams top scores in a new study by KLAS Research,Women’s Imaging 2015. Are New Technologies Delivering Promised Benefits? 1
In the study, mammography providers scored Hologic highest in all 11 performance measures evaluated by KLAS. For example:
- 95% of users said they would buy from Hologic again.
- 67% of users said Hologic was their best mammography vendor.
The researchers noted that Hologic 3D Mammography™ stands out for technology innovation and high image quality, and that its C-View™ software is strengthening satisfaction and encouraging adoption.
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States and internationally. The company operates in four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health.
Finally, Inovio Pharmaceuticals Inc (NASDAQ:INO), decreased -2.19%, to $7.13.
Inovio Pharmaceuticals, Inc. (INO) declared that the U.S. Defense Advanced Research Projects Agency (DARPA) has exercised its option to provide an additional $24 million to support the Inovio-led development of multiple treatment and prevention approaches against Ebola. The option exercise, part of the $45 million Ebola program grant declared in April when Inovio received an initial $21 million award, was contingent upon Inovio successfully leading the completion of certain pre-clinical and clinical development milestones.
DARPA has funded this program to develop a DNA-based vaccine against Ebola, a therapeutic DNA-based monoclonal antibody product (dMAb(TM)) to treat Ebola infection, and a conventional monoclonal antibody to treat Ebola.
Inovio Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and infectious diseases.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
